KMDA · Kamada Ltd · Metrics
$7.95
-0.10 (-1.24%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$464.57M
Shares
57.71M
Volume · Oct 28
58.89K
Avg daily vol (3M)
123.95K
KMDA metrics
78 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$8.05
Market cap
$464.57M
Price action
20 metricsPrice change (1W)
+2.5%
Price change (30D)
-6.6%
Price change (3M)
+14.0%
Price change (6M)
-1.2%
Price change (YTD)
+14.0%
Price change (1Y)
+14.5%
Trailing year
Price change (5Y)
+41.7%
52-week high
$9.31
52-week low
$6.62
Change from 52-week high
-13.5%
Change from 52-week low
+21.6%
Annualized volatility
35.1%
Annualized volatility (3M)
36.3%
Beta
1.0
RSI (14D)
51.7
Price vs SMA 50
-1.8%
Price vs SMA 200
+0.3%
Avg volume (3M)
123,948
Relative volume
0.6
Average dollar volume
$995,378
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
57.71M
Valuation
12 metricsP / E (TTM)
21.2
Trailing earnings · reciprocal yield 4.7%
PEG ratio
0.9
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.4×
reciprocal yield 41.9%
P / book
1.7
reciprocal yield 58.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
12.8
reciprocal yield 7.8%
Earnings yield
4.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
5.2%
Trailing 12 months
Payout ratio
—
Shareholder yield
3.1%
Dividend / share (TTM)
$0.42
Dividend growth YoY
+110.0%
Dividend growth streak
—
Last ex-dividend
2026-08-27
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
40.8%
Operating margin
14.5%
Trailing 12 months
Net margin
—
Gross profit (TTM)
$78.31M
Operating profit (TTM)
$27.83M
Net income (TTM)
$20.44M
Trailing 12 months
Diluted EPS (TTM)
$0.38
FCF margin
—
Effective tax rate
16.6%
Growth
11 metricsRevenue growth YoY
+22.7%
Year over year
Net income growth YoY
+37.1%
Revenue (TTM)
$191.85M
Trailing 12 months
EPS growth YoY
+23.1%
Shares change YoY
+0.3%
Year over year · more shares
Revenue CAGR (3Y)
+11.7%
Revenue CAGR (5Y)
+6.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-1.6%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
7.7%
Return on assets
5.4%
Debt / equity
—
Current ratio
4.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.3
Interest coverage
26.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$29.47M
Total assets
$383.16M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$35.76M
Capital expenditures (TTM)
—
R&D (TTM)
$9.91M
SG&A (TTM)
—
Stock compensation (TTM)
$2.10M
R&D / revenue
5.2%
Stock compensation / revenue
1.1%
Ownership (13F)
9 metrics13F filers
51
13F filer change QoQ
+8
Institutional ownership
8.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.0%
Holder tenure
18.0
Price vs estimated holder cost
+2.2%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.3%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
34 / 100
Insider activity
2 metricsNet insider buying (90D)
−$1.65M
Insider-sentiment score
26 / 100
Risk flags
1 metricsGoing concern
—